If the author’s manuscript is assessed as inappropriate to be published in his/her preferred journal, our editorial team may help the author in transferring the submission to a more appropriate Bentham Journal, through Bentham’s Manuscript Transfer Facility.
Transfer of Submission
Transfer of submission with Bentham’s Manuscript Transfer Facility is very simple.
The Author receives the transfer proposal by email - the transfer process is initiated by an affirmative response from the author to our transfer proposal.
The Authors’ manuscript is transferred to a suitable journal for initial editorial scrutiny.
The Author then receives an editorial decision from the journal.
Selection of another Journal
The Author is free to choose to submit the manuscript to a new journal by declining our transfer offer.
Our aim is to facilitate and develop rapid, effective and truly innovative solutions to facilitate our valued authors by enabling more options and better services to improve the publication process.
Jean-Marc Sabatier Laboratoire ERT 62 'Ingénierie des peptides à visée thérapeutique' Université de la Méditerranée Faculté de Médecine Nord Boulevard Pierre Dramard 13916 - MARSEILLE, Cedex 20 France
Jean-Marc SABATIER is a Director of research at the French CNRS, with PhD and HDR degrees in Biochemistry and Microbiology. He headed several academic research teams (CNRS, INSERM and University), as well as a combined academic-industry research laboratory devoted to the engineering of therapeutic peptides (ERT62, Marseilles, France). He was also a Director of Research for several French private companies as well as a Canadian public company. He acts as a Consultant for top pharmaceutical and cosmetic companies. Dr. Sabatier works in the field of animal toxins. He so far contributed to several books in toxinology and virology, and more than 160 scientific articles, 180 communications, and 53 patents in both biology and chemistry.